Pay in 4 interest-free payments of $5.37 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
You will need a professional to guide you on administering the injection properly if you are starting this treatment
Quality varies significantly between suppliers, making it essential to source from reputable vendors who provide third-party testing and certificates of analysis
AOD 9604 failed to achieve regulatory approval after early trials, and retatrutide remains in Phase 3 development without NICE or MHRA guidance
The starting dose is 2.5 mg per week
Potential benefits of MOTS-c: Improved insulin sensitivity Better glucose control Increased exercise capacity Enhanced mitochondrial function Improved metabolic flexibility Unlike Semaglutide or Tirzepatide, MOTS-c does not primarily work by reducing appetite
US$ 25.05
US$ 25.72
US$ 22.07
US$ 25.09
US$ 27.62
US$ 28.43
